At the end of September 2012, the EMCDDA and Europol examined the available information on a new psychoactive substance 5-(2-aminopropyl)indole (commonly known by the abbreviation ‘5-IT’), through a joint assessment. The two organisations concluded that sufficient information had been accumulated to merit the production of a Joint Report on 5-(2-aminopropyl)indole as stipulated by Article 5.1 of the Council Decision 2005/387/JHA.

Table of contents

Introduction
Information collection process
Information required by Article 5.2 of the Decision
Information from the EMA as requested by Article 5.3 of the Decision
Summary of findings
Conclusions

Annexes

Annex 1 — Main information sources
Annex 2 — Details of seizures and collected samples of 5-(2-aminopropyl)indole (5-IT) reported to the EMCDDA
Annex 3 — Deaths associated with 5-(2-aminopropylindole(5-IT) reported to the EMCDDA